Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1972 1
1973 1
1976 1
1981 1
1982 1
1988 1
1991 1
1995 1
1996 2
1997 2
1998 4
1999 3
2000 14
2001 7
2002 5
2003 1
2004 5
2005 13
2006 9
2007 6
2008 4
2009 4
2010 2
2011 6
2012 9
2013 4
2014 6
2015 3
2016 3
2017 4
2018 4
2019 11
2020 4
2021 9
2022 6
2023 5
2024 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

154 results

Results by year

Filters applied: . Clear all
Page 1
Sipuleucel-T immunotherapy for castration-resistant prostate cancer.
Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, Redfern CH, Ferrari AC, Dreicer R, Sims RB, Xu Y, Frohlich MW, Schellhammer PF; IMPACT Study Investigators. Kantoff PW, et al. N Engl J Med. 2010 Jul 29;363(5):411-22. doi: 10.1056/NEJMoa1001294. N Engl J Med. 2010. PMID: 20818862 Free article. Clinical Trial.
Comparative Effectiveness of Adalimumab vs Tofacitinib in Patients With Rheumatoid Arthritis in Australia.
Deakin CT, De Stavola BL, Littlejohn G, Griffiths H, Ciciriello S, Youssef P, Mathers D, Bird P, Smith T, O'Sullivan C, Freeman T, Segelov D, Hoffman D, Seaman SR; OPAL Rheumatology Network. Deakin CT, et al. JAMA Netw Open. 2023 Jun 1;6(6):e2320851. doi: 10.1001/jamanetworkopen.2023.20851. JAMA Netw Open. 2023. PMID: 37382956 Free PMC article. Clinical Trial.
Systemic lupus erythematosus: current management.
Godfrey TR, Ryan PF. Godfrey TR, et al. Med J Aust. 2001 Aug 6;175(3):125-6. doi: 10.5694/j.1326-5377.2001.tb143057.x. Med J Aust. 2001. PMID: 11548075 No abstract available.
Therapeutic advances in systemic lupus erythematosus.
Godfrey T, Khamashta MA, Hughes GR. Godfrey T, et al. Curr Opin Rheumatol. 1998 Sep;10(5):435-41. doi: 10.1097/00002281-199809000-00007. Curr Opin Rheumatol. 1998. PMID: 9746859 Review.
Association of systemic lupus erythematosus standard of care immunosuppressants with glucocorticoid use and disease outcomes: a multicentre cohort study.
de Luca Montes RA, Huq M, Godfrey T, Oon S, Calderone A, Kandane-Rathnayake R, Louthrenoo W, Luo SF, Jan Wu YJ, Golder V, Lateef A, Navarra SV, Zamora L, Hamijoyo L, Sockalingam S, An Y, Li Z, Katsumata Y, Harigai M, Chan M, Goldblatt F, O'Neill S, Lau CS, Cho J, Hoi A, Karyekar CS, Morand EF, Nikpour M. de Luca Montes RA, et al. Among authors: godfrey t. Adv Rheumatol. 2024 May 8;64(1):38. doi: 10.1186/s42358-024-00366-y. Adv Rheumatol. 2024. PMID: 38720354
154 results